Franco Mandelli

Active 1982–2019

103
Papers
22,398
Citations
85
h-index
103
i10-index

Citations

Citations per year for Franco Mandelli1948: 2 citations1963: 1 citations1977: 1 citations1984: 3 citations1985: 1 citations1986: 1 citations1987: 2 citations1988: 4 citations1989: 6 citations1990: 13 citations1991: 12 citations1992: 16 citations1993: 23 citations1994: 22 citations1995: 40 citations1996: 48 citations1997: 69 citations1998: 84 citations1999: 121 citations2000: 120 citations2001: 110 citations2002: 162 citations2003: 187 citations2004: 109 citations2005: 185 citations2006: 169 citations2007: 191 citations2008: 157 citations2009: 165 citations2010: 171 citations2011: 177 citations2012: 121 citations2013: 145 citations2014: 126 citations2015: 119 citations2016: 151 citations2017: 118 citations2018: 103 citations2019: 399 citations2020: 387 citations2021: 339 citations2022: 175 citations2023: 165 citations2024: 235 citations2025: 98 citations1949–1962: no citations, so these years are not shown1964–1976: no citations, so these years are not shown1978–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,714 citing papers, 26.2% of this breakdownItaly: 707 citing papers, 10.8% of this breakdownGermany: 556 citing papers, 8.5% of this breakdownUnited Kingdom: 476 citing papers, 7.3% of this breakdownFrance: 390 citing papers, 5.9% of this breakdownChina: 318 citing papers, 4.9% of this breakdownNetherlands: 238 citing papers, 3.6% of this breakdownSpain: 232 citing papers, 3.5% of this breakdownCanada: 182 citing papers, 2.8% of this breakdownJapan: 158 citing papers, 2.4% of this breakdownSwitzerland: 124 citing papers, 1.9% of this breakdownSweden: 111 citing papers, 1.7% of this breakdown
0%26.2%Other 20.5%

Fields

  • Medicine75.1%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Immunology and Microbiology1.8%
  • Computer Science0.7%
  • Mathematics0.3%
  • Chemistry0.2%
  • Other1.1%

Topics

  • Acute Myeloid Leukemia Research13.1%
  • Acute Lymphoblastic Leukemia research6.6%
  • Retinoids in leukemia and cellular processes5.3%
  • Lymphoma Diagnosis and Treatment5.1%
  • Chronic Myeloid Leukemia Treatments4.5%
  • Chronic Lymphocytic Leukemia Research3.2%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Link, Maria Grazia Kropp, Alessandro Rambaldi, Giorgio La Nasa, Mario Luppi, Fabio Ciceri, Olimpia Finizio, Adriano Venditti, Francesco Fabbiano, Konstanze Döhner, Michaela Sauer, Arnold Ganser, Sergio Amadori, Franco Mandelli, Hartmut Döhner, Gerhard Ehninger, Richard F. Schlenk, Uwe Platzbecker - New England Journal of Medicine 2013 cited by 1,606

  2. Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 1,885

  3. A Prognostic Score for Advanced Hodgkin's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1998 cited by 1,733

  4. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 461

  5. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiara Frairia, Enrico Maria Pogliani, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Journal of Clinical Oncology 2016 cited by 392

  6. Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 256

  7. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2013 cited by 178

  8. Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2016 cited by 80

  9. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Authors: , , , , , , , , , , , , , , , , , , , - 2000 cited by 632

  10. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival

    Authors: , , , , , , , - Blood 2003 cited by 361

  11. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 186

  12. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2013 cited by 141

  13. Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia

    Authors: , , , , , , , , - Haematologica 2013 cited by 118

  14. High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adriano Venditti, Anne Hagemeijer, Marco Mancini, Joop H. Jansen, Daniela Cilloni, Liv Meert, Paola Fazi, Marco Vignetti, Silvia Maria Trisolini, Franco Mandelli, Théo de Witte - Journal of Clinical Oncology 2013 cited by 168

  15. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features

    Authors: , , , , , , , , , , - Leukemia 2006 cited by 122

  16. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

    Authors: , , , , , , , , , , , , , , , , - Blood 2007 cited by 373

  17. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.

    Authors: , , , , , , , - Journal of Clinical Oncology 1991 cited by 171

  18. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2010 cited by 342

  19. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

    Authors: , , , , , , , , , , , , , , , , , , - Haematologica 2016 cited by 99

  20. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Link, Chiara Frairia, Claudio Fozza, Alfonso Maria D’Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Sergio Amadori, Franco Mandelli, Maria Teresa Voso, Gerhard Ehninger, Richard F. Schlenk, Francesco Lo‐Coco - Leukemia 2019 cited by 71

  21. Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature review

    Authors: , , , , , , , - American Journal of Hematology 2001 cited by 432

  22. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation

    Authors: , , , , , , , , , - The Lancet 1994 cited by 278

  23. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

    Authors: , , , , , , , , - Haematologica 2007 cited by 207

  24. Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation

    Authors: , , , , , , , - Clinical Cancer Research 2005 cited by 141